USD
+$0.00
(+0.00%
)At Close (As of Sep 9, 2025)
$47.43M
Market Cap
-
P/E Ratio
-1.39
EPS
$2.31
52 Week High
$0.16
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $5M |
Total Revenue | $5.8M |
Cost Of Revenue | $852K |
Costof Goods And Services Sold | $852K |
Operating Income | -$15M |
Selling General And Administrative | $9.9M |
Research And Development | $11M |
Operating Expenses | $20M |
Investment Income Net | - |
Net Interest Income | -$3.5M |
Interest Income | $273K |
Interest Expense | $3.7M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $852K |
Income Before Tax | -$13M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$13M |
Comprehensive Income Net Of Tax | - |
Ebit | -$9.3M |
Ebitda | -$8.4M |
Net Income | -$13M |
Field | Value (USD) |
---|---|
Total Assets | $6.6M |
Total Current Assets | $5.3M |
Cash And Cash Equivalents At Carrying Value | $76K |
Cash And Short Term Investments | $76K |
Inventory | - |
Current Net Receivables | $571K |
Total Non Current Assets | $1.4M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $469K |
Intangible Assets Excluding Goodwill | $469K |
Goodwill | $372K |
Investments | - |
Long Term Investments | - |
Short Term Investments | $3.5M |
Other Current Assets | $1.1M |
Other Non Current Assets | - |
Total Liabilities | $16M |
Total Current Liabilities | $16M |
Current Accounts Payable | $9.5M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $3.3M |
Total Non Current Liabilities | $31K |
Capital Lease Obligations | $75K |
Long Term Debt | - |
Current Long Term Debt | $3.3M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $3.4M |
Other Current Liabilities | $2.7M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$8.9M |
Treasury Stock | - |
Retained Earnings | -$493M |
Common Stock | $6K |
Common Stock Shares Outstanding | $7.7M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$11M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $723K |
Capital Expenditures | $146K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$4.1M |
Cashflow From Financing | $6.2M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$374K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$13M |
Field | Value (USD) |
---|---|
Gross Profit | $5M |
Total Revenue | $5.8M |
Cost Of Revenue | $852K |
Costof Goods And Services Sold | $852K |
Operating Income | -$15M |
Selling General And Administrative | $9.9M |
Research And Development | $11M |
Operating Expenses | $20M |
Investment Income Net | - |
Net Interest Income | -$3.5M |
Interest Income | $273K |
Interest Expense | $3.7M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $852K |
Income Before Tax | -$13M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$13M |
Comprehensive Income Net Of Tax | - |
Ebit | -$9.3M |
Ebitda | -$8.4M |
Net Income | -$13M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing, and commercialization of treatments for patients with cancer and other diseases. The company is headquartered in Austin, Texas.